ResMed Inc (RMD)
184.22
+3.87
(+2.15%)
USD |
NYSE |
Apr 23, 16:00
184.22
0.00 (0.00%)
After-Hours: 19:33
ResMed Cash from Investing (Quarterly): -41.14M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -41.14M |
| September 30, 2023 | -148.98M |
| June 30, 2023 | -46.52M |
| March 31, 2023 | -28.10M |
| December 31, 2022 | -1.026B |
| September 30, 2022 | -58.81M |
| June 30, 2022 | -55.24M |
| March 31, 2022 | -49.50M |
| December 31, 2021 | -83.31M |
| September 30, 2021 | -41.87M |
| June 30, 2021 | -48.07M |
| March 31, 2021 | -58.62M |
| December 31, 2020 | -29.66M |
| September 30, 2020 | -22.11M |
| June 30, 2020 | -3.407M |
| March 31, 2020 | -99.61M |
| December 31, 2019 | -43.62M |
| September 30, 2019 | -33.22M |
| June 30, 2019 | -43.89M |
| March 31, 2019 | -225.41M |
| December 31, 2018 | -658.22M |
| September 30, 2018 | -148.19M |
| June 30, 2018 | -38.53M |
| March 31, 2018 | -19.62M |
| December 31, 2017 | -28.26M |
| Date | Value |
|---|---|
| September 30, 2017 | -15.42M |
| June 30, 2017 | -31.28M |
| March 31, 2017 | -17.92M |
| December 31, 2016 | -19.52M |
| September 30, 2016 | -13.17M |
| June 30, 2016 | -818.16M |
| March 31, 2016 | -83.73M |
| December 31, 2015 | -161.11M |
| September 30, 2015 | -62.75M |
| June 30, 2015 | -23.48M |
| March 31, 2015 | -19.00M |
| December 31, 2014 | -59.00M |
| September 30, 2014 | -41.60M |
| June 30, 2014 | -22.84M |
| March 31, 2014 | -23.20M |
| December 31, 2013 | -27.36M |
| September 30, 2013 | -21.59M |
| June 30, 2013 | -26.48M |
| March 31, 2013 | -21.00M |
| December 31, 2012 | -15.53M |
| September 30, 2012 | -14.98M |
| June 30, 2012 | -8.151M |
| March 31, 2012 | -5.811M |
| December 31, 2011 | -15.97M |
| September 30, 2011 | -71.68M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.026B
Minimum
Dec 2022
-3.407M
Maximum
Jun 2020
-103.27M
Average
-46.52M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -152.00M |
| Boston Scientific Corp | -1.053B |
| Integer Holdings Corp | -80.58M |
| Haemonetics Corp | -268.94M |
| Insulet Corp | -31.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 272.83M |
| Cash from Financing (Quarterly) | -238.96M |
| Free Cash Flow | 943.73M |
| Free Cash Flow Per Share (Quarterly) | 1.683 |
| Free Cash Flow to Equity (Quarterly) | 383.02M |
| Free Cash Flow to Firm (Quarterly) | 259.38M |
| Free Cash Flow Yield | 3.47% |